Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.05049 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.02547 | 82 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.98344 | 82 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.79268 | 80 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.99159 | 82 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.82339 | 83 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.5371 | 80 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.41156 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.38361 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.0435 | 82 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.40718 | 85 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.43448 | 85 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.43006 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.75418 | 88 |